tiprankstipranks
Trending News
More News >
Ikonisys SA (DE:9W8)
:9W8
Advertisement

Ikonisys SA (9W8) Price & Analysis

Compare
0 Followers

9W8 Stock Chart & Stats

€1.42
-€0.01(-0.71%)
At close: 4:00 PM EST
€1.42
-€0.01(-0.71%)

9W8 FAQ

What was Ikonisys SA’s price range in the past 12 months?
Ikonisys SA lowest stock price was €1.28 and its highest was €1.55 in the past 12 months.
    What is Ikonisys SA’s market cap?
    Ikonisys SA’s market cap is €19.98M.
      When is Ikonisys SA’s upcoming earnings report date?
      Ikonisys SA’s upcoming earnings report date is Oct 23, 2026 which is in 336 days.
        How were Ikonisys SA’s earnings last quarter?
        Ikonisys SA released its earnings results on Oct 24, 2025. The company reported -€0.073 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.073.
          Is Ikonisys SA overvalued?
          According to Wall Street analysts Ikonisys SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Ikonisys SA pay dividends?
            Ikonisys SA does not currently pay dividends.
            What is Ikonisys SA’s EPS estimate?
            Ikonisys SA’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Ikonisys SA have?
            Ikonisys SA has 14,024,232 shares outstanding.
              What happened to Ikonisys SA’s price movement after its last earnings report?
              Ikonisys SA reported an EPS of -€0.073 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.128%.
                Which hedge fund is a major shareholder of Ikonisys SA?
                Currently, no hedge funds are holding shares in DE:9W8

                Company Description

                Ikonisys SA

                Ikonisys S.A., a cell based diagnostics company, engages in the design, manufacturing, marketing, and sale of medical diagnostic products for various cancers in the United States and Europe. It offers Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, and real-time image capture and analysis, and eliminates various factors that cause human error in testing; oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; and oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of rearrangements of the gene encoding anaplastic lymphoma kinase (ALK). The company also provides oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer CS, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; Ikonisoft explorer tissue, a FISH scanning application for analysis of various tissue section hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. Ikonisys S.A. is based in Paris, France.

                Ikonisys SA (9W8) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                MAUNA KEA TECHNOLOGIES
                Theraclion SA
                Diagnostic Medical Systems
                Euromedis Groupe SA
                Median Technologies
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis